medimpo limited Company Information
Company Number
01761386
Website
www.medimpo.comRegistered Address
63 imperial way, croydon, croydon, CR0 4RR
Industry
Dispensing chemist in specialised stores
Telephone
02086639052
Next Accounts Due
August 2024
Group Structure
View All
Shareholders
medimpo holdings limited 100%
medimpo limited Estimated Valuation
Pomanda estimates the enterprise value of MEDIMPO LIMITED at £788.3k based on a Turnover of £3.5m and 0.23x industry multiple (adjusted for size and gross margin).
medimpo limited Estimated Valuation
Pomanda estimates the enterprise value of MEDIMPO LIMITED at £0 based on an EBITDA of £-389.1k and a 2.23x industry multiple (adjusted for size and gross margin).
medimpo limited Estimated Valuation
Pomanda estimates the enterprise value of MEDIMPO LIMITED at £1m based on Net Assets of £515.1k and 2.03x industry multiple (adjusted for liquidity).
Medimpo Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Medimpo Limited Overview
Medimpo Limited is a live company located in croydon, CR0 4RR with a Companies House number of 01761386. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 1983, it's largest shareholder is medimpo holdings limited with a 100% stake. Medimpo Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.5m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medimpo Limited Health Check
Pomanda's financial health check has awarded Medimpo Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
7 Weak
Size
annual sales of £3.5m, make it smaller than the average company (£11.4m)
- Medimpo Limited
£11.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -8%, show it is growing at a slower rate (5.4%)
- Medimpo Limited
5.4% - Industry AVG
Production
with a gross margin of 32.6%, this company has a comparable cost of product (32.6%)
- Medimpo Limited
32.6% - Industry AVG
Profitability
an operating margin of -11.4% make it less profitable than the average company (4.8%)
- Medimpo Limited
4.8% - Industry AVG
Employees
with 34 employees, this is below the industry average (85)
34 - Medimpo Limited
85 - Industry AVG
Pay Structure
on an average salary of £21.6k, the company has an equivalent pay structure (£21.6k)
- Medimpo Limited
£21.6k - Industry AVG
Efficiency
resulting in sales per employee of £102.7k, this is less efficient (£135.2k)
- Medimpo Limited
£135.2k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is later than average (30 days)
- Medimpo Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 82 days, this is slower than average (72 days)
- Medimpo Limited
72 days - Industry AVG
Stock Days
it holds stock equivalent to 41 days, this is more than average (30 days)
- Medimpo Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 22 weeks, this is average cash available to meet short term requirements (18 weeks)
22 weeks - Medimpo Limited
18 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 64.4%, this is a similar level of debt than the average (64.3%)
64.4% - Medimpo Limited
64.3% - Industry AVG
medimpo limited Credit Report and Business Information
Medimpo Limited Competitor Analysis
Perform a competitor analysis for medimpo limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
medimpo limited Ownership
MEDIMPO LIMITED group structure
Medimpo Limited has no subsidiary companies.
medimpo limited directors
Medimpo Limited currently has 4 directors. The longest serving directors include Mr Rajendra Patel (May 1992) and Mrs Vandna Patel (May 1992).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Rajendra Patel | 69 years | May 1992 | - | Director | |
Mrs Vandna Patel | United Kingdom | 67 years | May 1992 | - | Director |
Ms Sandhya Patel | United Kingdom | 67 years | May 1992 | - | Director |
Mr Kiran Patel | United Kingdom | 65 years | Dec 2013 | - | Director |
MEDIMPO LIMITED financials
Medimpo Limited's latest turnover from November 2022 is estimated at £3.5 million and the company has net assets of £515.1 thousand. According to their latest financial statements, Medimpo Limited has 34 employees and maintains cash reserves of £394.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9,925,915 | 10,982,346 | 12,240,205 | 12,154,670 | 11,607,973 | 12,522,499 | 14,002,606 | 10,452,795 | ||||||
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
Cost Of Sales | 9,552,478 | 9,235,715 | 8,955,405 | 10,936,919 | 8,000,230 | |||||||||
Gross Profit | 2,687,727 | 2,918,955 | 2,652,568 | 3,065,687 | 2,452,565 | |||||||||
Admin Expenses | 2,617,561 | 2,785,983 | 2,155,150 | 2,290,193 | 1,779,346 | |||||||||
Operating Profit | 679,097 | 76,306 | 70,166 | 132,972 | 497,418 | -47,563 | 775,494 | 673,219 | ||||||
Interest Payable | 31,883 | 23,580 | 24,916 | 31,365 | 48,854 | 55,251 | 56,639 | 89,112 | ||||||
Interest Receivable | 0 | 0 | 138 | 271 | 229 | 350 | 523 | 310 | ||||||
Pre-Tax Profit | 647,214 | 52,726 | 45,388 | 101,878 | 448,793 | -102,464 | 719,378 | 584,417 | ||||||
Tax | -132,454 | -48,313 | -48,460 | -66,438 | -150,437 | -5,926 | -257,265 | -211,386 | ||||||
Profit After Tax | 514,760 | 4,413 | -3,072 | 35,440 | 298,356 | -108,390 | 462,113 | 373,031 | ||||||
Dividends Paid | 90,000 | 144,000 | 82,500 | 92,400 | 92,400 | 129,536 | 241,384 | 206,580 | ||||||
Retained Profit | 424,760 | -139,587 | -85,572 | -56,960 | 205,956 | -237,926 | 220,729 | 166,451 | ||||||
Employee Costs | 1,115,813 | 1,169,888 | 1,057,659 | 1,179,148 | 714,243 | 888,922 | 906,546 | 445,038 | ||||||
Number Of Employees | 34 | 35 | 47 | 51 | 60 | 63 | 62 | 57 | 56 | 53 | 46 | 44 | 40 | 41 |
EBITDA* | 900,579 | 485,789 | 499,423 | 561,508 | 919,137 | 370,398 | 1,196,014 | 1,098,454 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 31,205 | 39,207 | 94,515 | 200,672 | 223,494 | 905,563 | 996,634 | 1,026,806 | 1,064,120 | 1,075,986 | 1,014,209 | 979,533 | 1,001,099 | 983,300 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 191,310 | 572,822 | 969,217 | 1,365,612 | 1,762,007 | 2,158,402 | 2,554,797 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 31,205 | 39,207 | 94,515 | 200,672 | 223,494 | 905,663 | 996,734 | 1,218,216 | 1,637,042 | 2,045,303 | 2,379,921 | 2,741,640 | 3,159,601 | 3,538,197 |
Stock & work in progress | 267,200 | 279,254 | 387,481 | 549,947 | 539,164 | 1,046,573 | 860,614 | 988,129 | 1,138,873 | 958,244 | 683,000 | 790,000 | 890,000 | 465,400 |
Trade Debtors | 356,325 | 277,019 | 714,845 | 478,778 | 474,764 | 884,295 | 1,066,027 | 1,029,728 | 929,589 | 656,659 | 706,342 | 1,156,916 | 1,163,145 | 1,968,632 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 397,289 | 178,313 | 188,553 | 347,173 | 237,776 | 395,207 | 202,496 | 238,444 | 180,621 | 245,073 | 121,789 | 243,757 | 203,902 | 74,550 |
Cash | 394,497 | 1,410,781 | 407,688 | 627,248 | 1,618,759 | 1,295,354 | 1,868,568 | 1,263,313 | 1,336,845 | 1,716,135 | 1,235,467 | 859,866 | 1,320,532 | 1,416,374 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,415,311 | 2,145,367 | 1,698,567 | 2,003,146 | 2,870,463 | 3,621,429 | 3,997,705 | 3,519,614 | 3,585,928 | 3,576,111 | 2,746,598 | 3,050,539 | 3,577,579 | 3,924,956 |
total assets | 1,446,516 | 2,184,574 | 1,793,082 | 2,203,818 | 3,093,957 | 4,527,092 | 4,994,439 | 4,737,830 | 5,222,970 | 5,621,414 | 5,126,519 | 5,792,179 | 6,737,180 | 7,463,153 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 186,871 | 0 | 0 | 134,601 | 262,068 | 0 | 398,404 | 388,193 | 374,855 |
Bank loan | 0 | 0 | 53,733 | 86,573 | 216,602 | 0 | 181,744 | 165,463 | 0 | 155,694 | 589,256 | 589,256 | 556,205 | 546,166 |
Trade Creditors | 533,947 | 469,807 | 700,965 | 856,148 | 810,866 | 1,620,875 | 1,613,998 | 1,771,658 | 2,076,056 | 2,127,871 | 1,824,135 | 1,862,889 | 1,894,749 | 2,594,018 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 177,276 | 307,276 | 241,376 | 342,234 | 272,811 | 333,771 | 186,101 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 391,330 | 823,531 | 974,389 | 158,007 | 361,264 | 284,664 | 458,945 | 286,598 | 308,026 | 236,303 | 259,197 | 180,885 | 384,114 | 252,817 |
total current liabilities | 925,277 | 1,293,338 | 1,729,087 | 1,100,728 | 1,388,732 | 2,092,410 | 2,254,687 | 2,400,995 | 2,825,959 | 3,023,312 | 3,014,822 | 3,304,245 | 3,557,032 | 3,953,957 |
loans | 0 | 0 | 23,129 | 596,726 | 1,203,569 | 1,419,282 | 1,608,088 | 1,555,972 | 1,470,308 | 1,581,889 | 1,055,586 | 1,644,842 | 2,089,766 | 2,645,702 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 6,103 | 6,103 | 13,457 | 28,950 | 28,950 | 32,025 | 37,289 | 41,248 | 47,501 | 51,439 | 34,377 | 27,314 | 36,678 | 30,519 |
total long term liabilities | 6,103 | 6,103 | 36,586 | 625,676 | 1,232,519 | 1,451,307 | 1,645,377 | 1,597,220 | 1,517,809 | 1,633,328 | 1,089,963 | 1,672,156 | 2,126,444 | 2,676,221 |
total liabilities | 931,380 | 1,299,441 | 1,765,673 | 1,726,404 | 2,621,251 | 3,543,717 | 3,900,064 | 3,998,215 | 4,343,768 | 4,656,640 | 4,104,785 | 4,976,401 | 5,683,476 | 6,630,178 |
net assets | 515,136 | 885,133 | 27,409 | 477,414 | 472,706 | 983,375 | 1,094,375 | 739,615 | 879,202 | 964,774 | 1,021,734 | 815,778 | 1,053,704 | 832,975 |
total shareholders funds | 515,136 | 885,133 | 27,409 | 477,414 | 472,706 | 983,375 | 1,094,375 | 739,615 | 879,202 | 964,774 | 1,021,734 | 815,778 | 1,053,704 | 832,975 |
Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 679,097 | 76,306 | 70,166 | 132,972 | 497,418 | -47,563 | 775,494 | 673,219 | ||||||
Depreciation | 8,002 | 14,584 | 32,009 | 17,950 | 20,353 | 91,071 | 30,172 | 27,971 | 32,862 | 32,141 | 25,324 | 21,566 | 24,125 | 22,545 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 191,310 | 381,512 | 396,395 | 396,395 | 396,395 | 396,395 | 396,395 | 402,690 |
Tax | -132,454 | -48,313 | -48,460 | -66,438 | -150,437 | -5,926 | -257,265 | -211,386 | ||||||
Stock | -12,054 | -108,227 | -162,466 | 10,783 | -507,409 | 185,959 | -127,515 | -150,744 | 180,629 | 275,244 | -107,000 | -100,000 | 424,600 | 465,400 |
Debtors | 298,282 | -448,066 | 77,447 | 113,411 | -566,962 | 10,979 | 351 | 157,962 | 208,478 | 73,601 | -572,542 | 33,626 | -676,135 | 2,043,182 |
Creditors | 64,140 | -231,158 | -155,183 | 45,282 | -810,009 | 6,877 | -157,660 | -304,398 | -51,815 | 303,736 | -38,754 | -31,860 | -699,269 | 2,594,018 |
Accruals and Deferred Income | -432,201 | -150,858 | 816,382 | -203,257 | 76,600 | -174,281 | 172,347 | -21,428 | 71,723 | -22,894 | 78,312 | -203,229 | 131,297 | 252,817 |
Deferred Taxes & Provisions | 0 | -7,354 | -15,493 | 0 | -3,075 | -5,264 | -3,959 | -6,253 | -3,938 | 17,062 | 7,063 | -9,364 | 6,159 | 30,519 |
Cash flow from operations | 906,017 | 98,179 | 77,826 | 444,129 | 1,494,863 | 186,393 | 628,471 | 1,255,840 | ||||||
Investing Activities | ||||||||||||||
capital expenditure | 0 | 8,700 | -20,996 | -93,918 | -60,000 | 0 | -41,924 | -48,188 | ||||||
Change in Investments | 0 | 0 | 0 | 0 | -100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 |
cash flow from investments | 0 | 8,700 | -20,996 | -93,918 | -60,000 | 0 | -41,924 | -48,288 | ||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | -53,733 | -32,840 | -130,029 | 216,602 | -181,744 | 16,281 | 165,463 | -155,694 | -433,562 | 0 | 33,051 | 10,039 | 546,166 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | -177,276 | -130,000 | 65,900 | -100,858 | 69,423 | -60,960 | 147,670 | 186,101 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | -23,129 | -573,597 | -606,843 | -215,713 | -188,806 | 52,116 | 85,664 | -111,581 | 526,303 | -589,256 | -444,924 | -555,936 | 2,645,702 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | -31,883 | -23,580 | -24,778 | -31,094 | -48,625 | -54,901 | -56,116 | -88,802 | ||||||
cash flow from financing | -210,762 | 97,547 | -226,153 | -39,211 | -568,458 | -527,734 | -454,343 | 3,955,691 | ||||||
cash and cash equivalents | ||||||||||||||
cash | -1,016,284 | 1,003,093 | -219,560 | -991,511 | 323,405 | -573,214 | 605,255 | -73,532 | -379,290 | 480,668 | 375,601 | -460,666 | -95,842 | 1,416,374 |
overdraft | 0 | 0 | 0 | 0 | -186,871 | 186,871 | 0 | -134,601 | -127,467 | 262,068 | -398,404 | 10,211 | 13,338 | 374,855 |
change in cash | -1,016,284 | 1,003,093 | -219,560 | -991,511 | 510,276 | -760,085 | 605,255 | 61,069 | -251,823 | 218,600 | 774,005 | -470,877 | -109,180 | 1,041,519 |
P&L
November 2022turnover
3.5m
+15%
operating profit
-397.1k
0%
gross margin
32.6%
+2.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2022net assets
515.1k
-0.42%
total assets
1.4m
-0.34%
cash
394.5k
-0.72%
net assets
Total assets minus all liabilities
medimpo limited company details
company number
01761386
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
October 1983
age
41
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
63 imperial way, croydon, croydon, CR0 4RR
last accounts submitted
November 2022
medimpo limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 22 charges/mortgages relating to medimpo limited. Currently there are 4 open charges and 18 have been satisfied in the past.
medimpo limited Companies House Filings - See Documents
date | description | view/download |
---|